Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast - PubMed (original) (raw)
. 1991 Aug 23;253(5022):905-9.
doi: 10.1126/science.1715094.
Affiliations
- PMID: 1715094
- DOI: 10.1126/science.1715094
Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast
J Heitman et al. Science. 1991.
Abstract
FK506 and rapamycin are related immunosuppressive compounds that block helper T cell activation by interfering with signal transduction. In vitro, both drugs bind and inhibit the FK506-binding protein (FKBP) proline rotamase. Saccharomyces cerevisiae cells treated with rapamycin irreversibly arrested in the G1 phase of the cell cycle. An FKBP-rapamycin complex is concluded to be the toxic agent because (i) strains that lack FKBP proline rotamase, encoded by FPR1, were viable and fully resistant to rapamycin and (ii) FK506 antagonized rapamycin toxicity in vivo. Mutations that conferred rapamycin resistance altered conserved residues in FKBP that are critical for drug binding. Two genes other than FPR1, named TOR1 and TOR2, that participate in rapamycin toxicity were identified. Nonallelic noncomplementation between FPR1, TOR1, and TOR2 alleles suggests that the products of these genes may interact as subunits of a protein complex. Such a complex may mediate nuclear entry of signals required for progression through the cell cycle.
Similar articles
- A novel FK506- and rapamycin-binding protein (FPR3 gene product) in the yeast Saccharomyces cerevisiae is a proline rotamase localized to the nucleolus.
Benton BM, Zang JH, Thorner J. Benton BM, et al. J Cell Biol. 1994 Nov;127(3):623-39. doi: 10.1083/jcb.127.3.623. J Cell Biol. 1994. PMID: 7525596 Free PMC article. - FK 506-binding protein proline rotamase is a target for the immunosuppressive agent FK 506 in Saccharomyces cerevisiae.
Heitman J, Movva NR, Hiestand PC, Hall MN. Heitman J, et al. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1948-52. doi: 10.1073/pnas.88.5.1948. Proc Natl Acad Sci U S A. 1991. PMID: 1705713 Free PMC article. - TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin.
Lorenz MC, Heitman J. Lorenz MC, et al. J Biol Chem. 1995 Nov 17;270(46):27531-7. doi: 10.1074/jbc.270.46.27531. J Biol Chem. 1995. PMID: 7499212 - Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.
Kunz J, Hall MN. Kunz J, et al. Trends Biochem Sci. 1993 Sep;18(9):334-8. doi: 10.1016/0968-0004(93)90069-y. Trends Biochem Sci. 1993. PMID: 7694398 Review. - Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells.
Wiederrecht GJ, Sabers CJ, Brunn GJ, Martin MM, Dumont FJ, Abraham RT. Wiederrecht GJ, et al. Prog Cell Cycle Res. 1995;1:53-71. doi: 10.1007/978-1-4615-1809-9_5. Prog Cell Cycle Res. 1995. PMID: 9552353 Review.
Cited by
- Biochemical curiosities : Piquing students' interest in biochemistry by exploring evolution's pursuit of the improbable.
Laxman S. Laxman S. EMBO Rep. 2024 Sep 13. doi: 10.1038/s44319-024-00259-7. Online ahead of print. EMBO Rep. 2024. PMID: 39271772 No abstract available. - mTOR Signaling: Roles in Hepatitis B Virus Infection and Hepatocellular Carcinoma.
Mei L, Sun H, Yan Y, Ji H, Su Q, Chang L, Wang L. Mei L, et al. Int J Biol Sci. 2024 Aug 1;20(11):4178-4189. doi: 10.7150/ijbs.95894. eCollection 2024. Int J Biol Sci. 2024. PMID: 39247820 Free PMC article. Review. - Loss of the putative Rab GTPase, Ypt7, impairs the virulence of Cryptococcus neoformans.
Hu G, Qu X, Bhalla K, Xue P, Bakkeren E, Lee CWJ, Kronstad JW. Hu G, et al. Front Microbiol. 2024 Jul 25;15:1437579. doi: 10.3389/fmicb.2024.1437579. eCollection 2024. Front Microbiol. 2024. PMID: 39119141 Free PMC article. - Synthetic Dimerization Approaches for In Vivo Studies in Saccharomyces cerevisiae.
Elsässer J, Kraft C. Elsässer J, et al. Methods Mol Biol. 2024;2845:27-37. doi: 10.1007/978-1-0716-4067-8_3. Methods Mol Biol. 2024. PMID: 39115655 - The target of rapamycin signaling pathway regulates vegetative development, aflatoxin biosynthesis, and pathogenicity in Aspergillus flavus.
Li G, Cao X, Tumukunde E, Zeng Q, Wang S. Li G, et al. Elife. 2024 Jul 11;12:RP89478. doi: 10.7554/eLife.89478. Elife. 2024. PMID: 38990939 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases